These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17802754)

  • 1. [Study of the efficacy of cyclosporine used in patients at high risk of keratograft rejection. Communication 1. Results of clinical monitoring].
    Makarov PV; Balaian TG; Oganesian OG; Slepova OS; Bykovskaia GN; Iluridze SL
    Vestn Oftalmol; 2007; 123(4):14-9. PubMed ID: 17802754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the efficacy of cyclosporine used in patients at high risk of keratograft rejection. Communication 2. Immunological treatment monitoring].
    Slepova OS; Bykovskaia GN; Makarov PV; Balaian TG; Oganesian OG; Iluridze SL
    Vestn Oftalmol; 2007; 123(4):19-22. PubMed ID: 17802755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of immunosuppressive therapy in reconstructive keratoplasty (experience gained in the use of cyclosporin)].
    Kasparov AA; Aladinskaia IV
    Vestn Oftalmol; 2002; 118(4):16-8. PubMed ID: 12371314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined penetrating keratoplasty and limbal allograft transplantation for severe corneal burns.
    Theng JT; Tan DT
    Ophthalmic Surg Lasers; 1997 Sep; 28(9):765-8. PubMed ID: 9304641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of penetrating keratoplasty in chronic and delayed mustard gas keratitis.
    Javadi MA; Yazdani S; Kanavi MR; Mohammadpour M; Baradaran-Rafiee A; Jafarinasab MR; Einollahi B; Karimian F; Zare M; Naderi M; Rabei HM
    Cornea; 2007 Oct; 26(9):1074-8. PubMed ID: 17893537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with cyclosporin A, with low doses, in high-risk penetrating keratoplasties. A bi-centric study of 90 cases].
    Robert PY; Delbosc B; Preux PM; Monnot PH; Drouet M; Peyronnet P; Adenis JP
    J Fr Ophtalmol; 1997; 20(7):507-14. PubMed ID: 9499974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratoplasty after mustard gas injury: clinical outcome and histology.
    Richter MN; Wachtlin J; Bechrakis NE; Hoffmann F
    Cornea; 2006 May; 25(4):467-9. PubMed ID: 16670487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A; Arlen D; Barrett B; Boucher A; Cardella C; Cockfield SM; Rush D; Paraskevas S; Shapiro J; Shoker A; Yilmaz S; Zaltzman JS; Kiberd B
    Transplantation; 2008 Oct; 86(7):953-60. PubMed ID: 18852662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.
    Troncoso P; Ortiz AM; Jara A; Vilches S
    Transplant Proc; 2009; 41(1):127-30. PubMed ID: 19249495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of corneal allograft rejection by systemic cyclosporine-A in heavily vascularized rabbit corneas following alkali burns.
    Rehany U; Waisman M
    Cornea; 1994 Sep; 13(5):447-53. PubMed ID: 7995070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine.
    Russ G; Jamieson N; Oberbauer R; Arias M; Murgia MG; Blancho G; Sato R; Stoeckl M; Revicki DA
    Transpl Int; 2007 Oct; 20(10):875-83. PubMed ID: 17854445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical burn to eye resulting in a heavy vascularized opaque cornea.
    Refract Corneal Surg; 1991; 7(5):395-7. PubMed ID: 1958629
    [No Abstract]   [Full Text] [Related]  

  • 16. [Applications of lecozyme with necrolytic purpose for subsequent keratoplasty in the treatment of eye burns: an experimental study].
    Chalanova RI
    Vestn Oftalmol; 2000; 116(3):7-10. PubMed ID: 10918840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Penetrating keratoplasty in combination with limbic transplantation in the rehabilitation of patients with total corneal leukomas of burn genesis].
    Chernysh VF; Boĭko EV; Dolgikh VM
    Vestn Oftalmol; 2007; 123(1):14-7. PubMed ID: 17361797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality.
    Roussel JC; Baron O; Périgaud C; Bizouarn P; Pattier S; Habash O; Mugniot A; Petit T; Michaud JL; Heymann MF; Treilhaud M; Trochu JN; Gueffet JP; Lamirault G; Duveau D; Despins P
    J Heart Lung Transplant; 2008 May; 27(5):486-93. PubMed ID: 18442713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.